Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-11

Clinical Trial Update: The Effect of Intralesian Injection of Umbilical Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide on Type 1:3 Collagen Ratio and Interleukin-10 Levels in Keloid: A Randomised Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized controlled trial evaluating intralesional umbilical cord mesenchymal stem cells, their conditioned medium, and triamcinolone acetonide on k…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Conditioned medium from umbilical cord mesenchymal stem cells (mesenchymal stem cell conditioned medium)
  • TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)
  • Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | Conditions: Keloid, Stem Cell | Phase 4 | Status: COMPLETED